E647-3825 Screening compound: 1-[1-(4-ethylpiperazin-1-yl)-1-oxobutan-2-yl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

E647-3825 Screening compound: 1-[1-(4-ethylpiperazin-1-yl)-1-oxobutan-2-yl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one
E647-3825 Screening compound: 1-[1-(4-ethylpiperazin-1-yl)-1-oxobutan-2-yl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound E647-3825
1-[1-(4-ethylpiperazin-1-yl)-1-oxobutan-2-yl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E647-3825

Molecular Formula

C20H29N3O2 (C20 H29 N3 O2)

Compound Name

1-[1-(4-ethylpiperazin-1-yl)-1-oxobutan-2-yl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

IUPAC name

1-[1-(4-ethylpiperazin-1-yl)-1-oxobutan-2-yl]-2345-tetrahydro-1H-1-benzazepin-2-one

SMILES

CCC(C(N1CCN(CC)CC1)=O)N(c1c(CCC2)cccc1)C2=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

343.47

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.368

Distribution Coefficient, logD

2.112

Water Solubility, LogSw

-2.40

Polar Surface Area

35.332

Acid Dissociation Constant (pKa)

22.16

Base Dissociation Constant (pKb)

7.30

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

60.00

E647-3825 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

CNS BBB Library (22607 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Ion Channels Focused Library (26372 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
  • Nervous system
  • Nervous system
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
  • Ion Channels
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E647-3825 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E647-3825?
Check Price and Availability of E647-3825, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E647-3825 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E647-3825
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E647-3825
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E647-3825 available by request